Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**CLM-IN01** is an investigational, single-prescription drug-device combination product from Closed Loop Medicine for chronic insomnia. It co-packages a novel 2 mg prolonged-release capsule formulation of an undisclosed known drug with Closed Loop Medicine's software as a medical device digital-therapeutic component, intended to integrate medication management and individualized digital care. The software component received UKCA marking and CE medical-device designation in 2021; the specific pharmacologic active ingredient and molecular target have not been publicly identified in the sources reviewed. ([closedloopmedicine.com](https://www.closedloopmedicine.com/closed-loop-medicine-secures-ukca-marking-and-receives-ce-designation-for-a-medical-device-that-will-form-part-of-its-insomnia-product-clm-in01/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CLM-IN01.